Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
Go back to Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 25.78 -0.46 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.24 | 52 Week High | $117.12 | |||
| Open | $28.39 | 52 Week Low | $46.52 | |||
| Day High | $28.50 | P/E | N/A | |||
| Day Low | $25.45 | EPS | $-1.97 | |||
| Volume | 2,171,409 | |||||
